Dr. Raphael Nir is presently the Co-Founder, President and CSO of SBH Sciences and SBH Diagnostics. Formerly, he was an Associate Principal Scientist at Schering-Plough Research Institute. I have 30 years of experience in molecular and cellular biotechnology, drug development, and good lab practice (GLP) for therapeutics. Additionally, he continue to manage the research and development activities with a focus on the development and implementation of immunoassays and efficient manufacturing of recombinant cytokines and enzymes. Dr. Nir is a world leader in these fields, having developed over 40 processes for protein production and over 300 bioassays to determine the biological activity of cytokines that are available for commercial use in the R&D market. As an angel Investor and experienced biotech entrepreneur, he has co-founded multiple biotechnology companies [(e.g., SBH Sciences, Woodland Biosciences - in-vivo CRO, SBH Diagnostics, Karyopharm Therapeutics (KPT), Alma BioTherapeutics, Galectin Sciences, Vuja De Sciences, and NeuroDex, Inc.)] and is a Managing Partner and CSO of ABI-LAB bioincubator (Natick, MA), which currently houses 20 start-up biotechnology companies.